Home
Sandoz

Sandoz Market Share Analysis for June 2026

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally.

Health > Biotechnology and Pharmaceuticals

Domainsandoz.at

Year Founded1886

Employees> 10001

Annual Revenue> $1B

Sandoz

Sandoz (including company regionals)

sandoz.at

See more website traffic and engagement information

Sandoz Revenue up to June 2026 is > 1B

revenue generated by Sandoz top domains

Sandoz top domains revenue over 3 years

Revenue for Sandoz top domains

sandoz.at> 1B

See more with Sales Intelligence

Total visits to Sandoz's top domains

Understand Sandoz market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sandoz.at3.8K

See more with Sales Intelligence

Avg. visit duration in Sandoz's top domains

Analyze Sandoz engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sandoz.at00:01:41

See more with Sales Intelligence

Avg. pageviews on Sandoz's top domains

See how Sandoz keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sandoz.at2.54

See more with Sales Intelligence

Sandoz top competitors by domain

Top similar sites in June 2026, ranked by their affinity

sandozfarma.esCompany NameSandoz IberiaEmployees501 - 1000HQSpain, MadridAnnual revenue--Total visits4.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Sandoz

These are the website technologies, by industry, used by Sandoz top domains

Conversion & Analytics (4)

Google Analytics

Social (4)

Instagram

Advertising (3)

DoubleClick

Audio Video Media (3)

YouTube

More Technologies

4

See all

News & Signals from Sandoz

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSandoz GmbH expanded facilities to Austria, Western Europe, Europe on Mar 21st '24.Sandoz opens new production facility in Kundl, Austria to significantly increase capacity for life-saving medicines.

NewsSandoz GmbH sold assets to Aspen Pharma Group in the amount of $101M on Dec 4th '23.Aspen Pharmacare will buy the Chinese business of Swiss group Sandoz, including commercialisation rights and intellectual property for some established products and those in the pipeline, for up to €92.6m ($100.6m), the South African company said on Monday, 4 December.

NewsBASF Corporation partnered with Sandoz GmbH on Apr 1st '21.In April 2021, BASF agreed with Sandoz GmbH, a subsidiary of Novartis, to invest at the Kundl/Schaftenau Campus in Austria.